Takeda Pharmaceutical (TAK) Tax Provisions (2017 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Tax Provisions of -$310.3 million for Q2 2026, down 70.4% year-over-year from -$1.0 billion in Q2 2025, and up 1.69% quarter-over-quarter from -$315.6 million in Q1 2026.
Takeda Pharmaceutical (TAK) Tax Provisions (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's Tax Provisions history runs 10 years deep, the most recent figure standing at -$310.3 million for Q2 2026.
- In Q2 2026, Tax Provisions fell 70.4% year-over-year to -$310.3 million; the TTM figure through Jun 2026 stood at -$717.5 million (down 12.68% YoY), while the FY2026 annual figure was $64.9 million, down 85.23% from the prior year.
- Tax Provisions for Q2 2026 stood at -$310.3 million, up from -$315.6 million in the prior quarter.
- The five-year high for Tax Provisions was $562.7 million in Q4 2025, with the low at -$734.0 million in Q1 2022.
- The 5-year median for Tax Provisions is -$289.2 million (2024), against an average of -$170.9 million.
- The sharpest annual moves came in 2022 and 2023: Tax Provisions plunged 267.46% in 2022, then jumped 1692.2% in 2023.
- Takeda Pharmaceutical's Tax Provisions stood at $84.9 million in 2022, then jumped by 254.55% to $301.1 million in 2023, then fell by 2.77% to $292.7 million in 2024, then soared by 92.24% to $562.7 million in 2025, then slumped by 155.15% to -$310.3 million in 2026.
- Business Quant data shows TAK's Tax Provisions at -$310.3 million in Q2 2026, -$315.6 million in Q1 2026, and $562.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn | -2.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -310.32 Mn |
| Mar 31, 2026 | -315.64 Mn |
| Dec 31, 2025 | 562.72 Mn |
| Sep 30, 2025 | -654.24 Mn |
| Jun 30, 2025 | -182.11 Mn |
| Mar 31, 2025 | -270.71 Mn |
| Dec 31, 2024 | 292.71 Mn |
| Sep 30, 2024 | -476.66 Mn |
| Jun 30, 2024 | -265.33 Mn |
| Mar 31, 2024 | -307.70 Mn |
| Dec 31, 2023 | 301.05 Mn |
| Sep 30, 2023 | 324.76 Mn |
| Jun 30, 2023 | -332.94 Mn |
| Mar 31, 2023 | -381.78 Mn |
| Dec 31, 2022 | 84.91 Mn |
| Sep 30, 2022 | -20.40 Mn |
| Jun 30, 2022 | -390.11 Mn |
| Mar 31, 2022 | -733.99 Mn |
| Dec 31, 2021 | -126.44 Mn |
| Sep 30, 2021 | -140.37 Mn |